ALIMTA Side Effects

6928786-2 | Atrial Fibrillation, Pericarditis
on Aug 05, 2010 Male patient from UNITED KINGDOM , weighting 147.9 lb, was diagnosed with mesothelioma (What is mesothelioma?) and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), pericarditis. Alimta dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ACETAMINOPHEN (1 G, As Needed) (View Acetaminophen Review and Acetaminophen Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), ANTIEMETICS AND ANTINAUSEANTS (View Antiemetics And Antinauseants Review and Antiemetics And Antinauseants Label ). Patient was hospitalized.

6927755-6 | Asthenia, Blood Count Abnormal, Blood Urine Present, Body Temperature Increased, Cognitive Disorder, Confusional State, Dysstasia, Muscle Rigidity, Rash Erythematous
Patient was taking Alimta (View Usage). Patient had the following side effects: asthenia, blood count abnormal, blood urine present, body temperature increased, cognitive disorder, confusional state, dysstasia, muscle rigidity, rash erythematous on Aug 16, 2010 from UNITED STATES Additional patient health information: Male patient , 81 years of age, weighting 180.0 lb, . Alimta dosage: . Patient was hospitalized.

6927195-X | Malignant Neoplasm Progression, Off Label Use
Adverse event was reported on Aug 10, 2010 by a Female patient taking Alimta (View Usage) (Dosage: 700 Mg, Other) was diagnosed with ovarian cancer metastatic and. Location: UNITED STATES , weighting 179.0 lb, After Alimta was administered, patient had the following side effects: malignant neoplasm progression, off label use. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ). Patient was hospitalized.

6920159-1 | Interstitial Lung Disease, Platelet Count Decreased
on Aug 05, 2010 Male patient from JAPAN , weighting 143.3 lb, was diagnosed with lung adenocarcinoma recurrent and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, platelet count decreased. Alimta dosage: 820 Mg, Other. During the same period patient was treated with AVASTIN (950 Mg, Other) (View Avastin Review and Avastin Label ), PARAPLATIN (440 Mg, Other) (View Paraplatin Review and Paraplatin Label ), PANVITAN (0.5 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), METHYCOBAL (500 Ug, Other) (View Methycobal Review and Methycobal Label ), GLIMICRON (40 Mg, 2/d) (View Glimicron Review and Glimicron Label ), BEZATOL (200 Meq, 2/d) (View Bezatol Review and Bezatol Label ), MUCODYNE (250 Meq, 3/d) (View Mucodyne Review and Mucodyne Label ), BIFUROXIN (2 D/f, 3/d) (View Bifuroxin Review and Bifuroxin Label ). Patient was hospitalized.


6920156-6 | Agranulocytosis, Circulatory Collapse, Multi-organ Failure, Off Label Use, Pancytopenia
on Aug 05, 2010 Female patient from GERMANY , 52 years of age, weighting 110.2 lb, was diagnosed with cervix carcinoma and was treated with Alimta (View Usage). Patient had the following side effects: agranulocytosis, circulatory collapse, multi-organ failure, off label use, pancytopenia. Alimta dosage: .

6920155-4 | Malignant Neoplasm Progression, Thrombocytopenia
Patient was taking Alimta (View Usage). After Alimta was administered, patient had the following side effects: malignant neoplasm progression, thrombocytopenia on Jul 30, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 147.7 lb, was diagnosed with non-small cell lung cancer stage iv and. Alimta dosage: 905 Mg, Unk. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLATE (View Folate Review and Folate Label ). Patient was hospitalized.

6917676-7 | Chills, Fatigue, Liver Function Test Abnormal, Platelet Count Decreased, Pyrexia, White Blood Cell Count Decreased
Adverse event was reported on Aug 02, 2010 by a Male patient taking Alimta (View Usage) (Dosage: 750 Mg, Other) was diagnosed with non-small cell lung cancer recurrent and. Location: JAPAN , weighting 144.4 lb, Patient experienced the following unwanted or unexpected effects: chills, fatigue, liver function test abnormal, platelet count decreased, pyrexia, white blood cell count decreased. During the same period patient was treated with PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), HYDROXOCOBALAMINE (View Hydroxocobalamine Review and Hydroxocobalamine Label ), FLUITRAN (2 Mg, Daily (1/d)) (View Fluitran Review and Fluitran Label ), AZELASTINE HCL (16 Mg, Daily (1/d)) (View Azelastine Hcl Review and Azelastine Hcl Label ), TENORMIN (25 Mg, Daily (1/d)) (View Tenormin Review and Tenormin Label ), MICARDIS (40 Mg, Daily (1/d)) (View Micardis Review and Micardis Label ), ZYLORIC (200 Mg, 2/d) (View Zyloric Review and Zyloric Label ), PROTECADIN (10 Mg, 2/d) (View Protecadin Review and Protecadin Label ). Patient was hospitalized.

6917673-1 | Intussusception, Pancreatitis Acute
on Jul 29, 2010 Male patient from AUSTRALIA , 62 years of age, was diagnosed with mesothelioma (What is mesothelioma?) and was treated with Alimta (View Usage). Patient had the following side effects: intussusception, pancreatitis acute. Alimta dosage: 500 Mg/m2, Every 3 Weeks. During the same period patient was treated with CISPLATIN (500 Mg/m2, Every 3 Weeks) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6915541-2 | Dermatitis Bullous, Rash Erythematous
on Jul 28, 2010 Female patient from BELGIUM , weighting 132.3 lb, was diagnosed with lung neoplasm, antiemetic supportive care and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: dermatitis bullous, rash erythematous. Alimta dosage: 500 Mg/m2, Once. During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LITICAN (View Litican Review and Litican Label ), ZOFRAN (View Zofran Review and Zofran Label ), MEDROL (View Medrol Review and Medrol Label ).

6915503-5 | Anaphylactic Shock, Eczema, Erythema, Hypersensitivity, Off Label Use, Pruritus, Rash, Rash Pruritic
Patient was taking Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, eczema (What is eczema?), erythema, hypersensitivity, off label use, pruritus, rash (What is rash?), rash pruritic on Jul 25, 2010 from JAPAN Additional patient health information: Female patient , weighting 108.0 lb, was diagnosed with pleural mesothelioma malignant, prophylaxis, cancer pain and. Alimta dosage: 500 Mg, Other. During the same period patient was treated with GEMZAR (Unk, Unk) (View Gemzar Review and Gemzar Label ), CISPLATIN (80 Mg, Other) (View Cisplatin Review and Cisplatin Label ), PARAPLATIN (Unk, Unk) (View Paraplatin Review and Paraplatin Label ), DECADRON /00016002/ (6.6 Mg, On The Day Pemetrexed Injection) (View Decadron /00016002/ Review and Decadron /00016002/ Label ), OXYCONTIN (Unk, Unk) (View Oxycontin Review and Oxycontin Label ), MOBIC (View Mobic Review and Mobic Label ), PANVITAN (0.5g, Daily (1/d)) (View Panvitan Review and Panvitan Label ).

6911486-2 | Blood Creatinine Increased, Mucosal Inflammation, Pleural Mesothelioma Malignant Recurrent
Adverse event was reported on Jul 27, 2010 by a Male patient taking Alimta (View Usage) (Dosage: 500 Mg/m2, Unk) was diagnosed with mesothelioma (What is mesothelioma?) and. Location: UNITED STATES , 80 years of age, Patient had the following side effects: blood creatinine increased, mucosal inflammation, pleural mesothelioma malignant recurrent. During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CISPLATIN (75 Mg/m2, Unk) (View Cisplatin Review and Cisplatin Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6911483-7 | Accidental Overdose, Incorrect Dose Administered
on Jul 26, 2010 Female patient from FRANCE , 85 years of age, was diagnosed with non-small cell lung cancer, vitamin supplementation, prophylaxis and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: accidental overdose, incorrect dose administered. Alimta dosage: . During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (Unk, Unk) (View Vitamin B-12 Review and Vitamin B-12 Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ).

6911481-3 | Mucosal Inflammation, Pharyngeal Disorder
on Jul 27, 2010 Female patient from UNITED STATES , 79 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: mucosal inflammation, pharyngeal disorder. Alimta dosage: 500 Mg/m2, Other. During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CISPLATIN (75 Mg/m2, Unk) (View Cisplatin Review and Cisplatin Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6909603-3 | Hepatic Function Abnormal
Patient was taking Alimta (View Usage). Patient had the following side effects: hepatic function abnormal on Jul 29, 2010 from JAPAN Additional patient health information: Male patient , 60 years of age, weighting 129.4 lb, was diagnosed with non-small cell lung cancer and. Alimta dosage: 500 Mg/m2, Other. During the same period patient was treated with FOLIAMIN (0.5 Mg, Daily (1/d)) (View Foliamin Review and Foliamin Label ), METHYCOBAL (1 Mg, Other) (View Methycobal Review and Methycobal Label ), ADALAT (10 Mg, Daily (1/d)) (View Adalat Review and Adalat Label ), DEPAKENE (200 Mg, Daily (1/d)) (View Depakene Review and Depakene Label ). Patient was hospitalized.

6907179-8 | Eczema, Erythema, Hypersensitivity, Off Label Use, Pruritus, Rash, Rash Pruritic
Adverse event was reported on Jul 25, 2010 by a Female patient taking Alimta (View Usage) (Dosage: 500 Mg, Other) was diagnosed with pleural mesothelioma malignant, prophylaxis, cancer pain and. Location: JAPAN , weighting 108.0 lb, After Alimta was administered, patient had the following side effects: eczema (What is eczema?), erythema, hypersensitivity, off label use, pruritus, rash (What is rash?), rash pruritic. During the same period patient was treated with GEMZAR (Unk, Unk) (View Gemzar Review and Gemzar Label ), CISPLATIN (80 Mg, Other) (View Cisplatin Review and Cisplatin Label ), PARAPLATIN (Unk, Unk) (View Paraplatin Review and Paraplatin Label ), DECADRON /00016002/ (6.6 Mg, On The Day Pemetrexed Injection) (View Decadron /00016002/ Review and Decadron /00016002/ Label ), OXYCONTIN (Unk, Unk) (View Oxycontin Review and Oxycontin Label ), MOBIC (View Mobic Review and Mobic Label ), PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ).

6902470-3 | Pneumonia, Pneumonitis
on Aug 02, 2010 Male patient from UNITED STATES , weighting 239.4 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), pneumonitis. Alimta dosage: 500mg/m2 Q 21 Days 042. During the same period patient was treated with GEMZAR (1250mg/m2 Q 21 Days + Day 8 042) (View Gemzar Review and Gemzar Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), RIFAXIMIN (View Rifaximin Review and Rifaximin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6902064-X | Nausea, Oropharyngeal Candidiasis, Pneumonia, Tachycardia
on Aug 02, 2010 Male patient from UNITED STATES , weighting 211.0 lb, was treated with Alimta (View Usage). Patient had the following side effects: nausea (What is nausea?), oropharyngeal candidiasis, pneumonia (What is pneumonia?), tachycardia. Alimta dosage: 1100 Mg. Patient was hospitalized.

6901769-4 | Bone Pain, Dermatitis, Rash
Patient was taking Alimta (View Usage). After Alimta was administered, patient had the following side effects: bone pain, dermatitis, rash (What is rash?) on Jul 22, 2010 from FRANCE Additional patient health information: Male patient , 40 years of age, . Alimta dosage: . During the same period patient was treated with SOLUPRED (View Solupred Review and Solupred Label ), ANTIHISTAMINES (View Antihistamines Review and Antihistamines Label ).

6885096-X | Liver Disorder, Platelet Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Jul 21, 2010 by a Male patient taking Alimta (View Usage) (Dosage: 750 Mg, Other) was diagnosed with liver disorder and. Location: JAPAN , weighting 144.4 lb, Patient experienced the following unwanted or unexpected effects: liver disorder, platelet count decreased, white blood cell count decreased. During the same period patient was treated with PANVITAN (View Panvitan Review and Panvitan Label ), HYDROXOCOBALAMINE (View Hydroxocobalamine Review and Hydroxocobalamine Label ). Patient was hospitalized.

6885095-8 | Colitis Ulcerative, Haemoglobin Decreased, Leukopenia, Platelet Count Decreased
on Jul 21, 2010 Female patient from AUSTRIA , 57 years of age, was diagnosed with mesothelioma (What is mesothelioma?) and was treated with Alimta (View Usage). Patient had the following side effects: colitis ulcerative, haemoglobin decreased, leukopenia, platelet count decreased. Alimta dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6880939-8 | Infection, Lymphangiosis Carcinomatosa, Pneumonitis
on Jul 22, 2010 Female patient from AUSTRALIA , 87 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: infection (What is infection?), lymphangiosis carcinomatosa, pneumonitis. Alimta dosage: .

6876988-6 | Abdominal Pain, Headache, Hyperhidrosis, Malaise, Off Label Use, Serotonin Syndrome
Patient was taking Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), headache (What is headache?), hyperhidrosis, malaise, off label use, serotonin syndrome on Jul 14, 2010 from JAPAN Additional patient health information: Female patient , 57 years of age, was diagnosed with non-small cell lung cancer and. Alimta dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), IRESSA (View Iressa Review and Iressa Label ). Patient was hospitalized.

6876944-8 | Off Label Use, Pancytopenia, Toxic Epidermal Necrolysis
Adverse event was reported on Jul 19, 2010 by a Female patient taking Alimta (View Usage) (Dosage: ) was diagnosed with bladder cancer (What is bladder cancer?) and. Location: GERMANY , 28 years of age, Patient had the following side effects: off label use, pancytopenia, toxic epidermal necrolysis.

6876931-X | Pancreatitis Acute
on Jul 14, 2010 Male patient from KOREA, REPUBLIC OF , 47 years of age, was diagnosed with lung neoplasm malignant, cough and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: pancreatitis acute. Alimta dosage: 800 Mg, Unk. During the same period patient was treated with ZIPEPROL (View Zipeprol Review and Zipeprol Label ), CODEINE SUL TAB (View Codeine Sul Tab Review and Codeine Sul Tab Label ), ACETAMINOPHEN (Er) (View Acetaminophen Review and Acetaminophen Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6872160-4 | Atrioventricular Block Second Degree, Sick Sinus Syndrome
on Jul 16, 2010 Male patient from MEXICO , 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block second degree, sick sinus syndrome. Alimta dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6867778-9 | Hyponatraemia, Pyrexia, Tuberculous Pleurisy
Patient was taking Alimta (View Usage). Patient had the following side effects: hyponatraemia, pyrexia, tuberculous pleurisy on Jul 14, 2010 from JAPAN Additional patient health information: Male patient , 65 years of age, weighting 123.5 lb, was diagnosed with lung adenocarcinoma recurrent and. Alimta dosage: Unk, Other. During the same period patient was treated with PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), OMEPRAL (20 Mg, Daily (1/d)) (View Omepral Review and Omepral Label ), MUCOSTA (100 Mg, 3/d) (View Mucosta Review and Mucosta Label ), CALONAL (400 Mg, 4/d) (View Calonal Review and Calonal Label ), MAGMITT (330 Mg, 3/d) (View Magmitt Review and Magmitt Label ), OXYCONTIN (15 Mg, 2/d) (View Oxycontin Review and Oxycontin Label ), HYDROXOCOBALAMIN ACETATE (1 Mg, Unk) (View Hydroxocobalamin Acetate Review and Hydroxocobalamin Acetate Label ). Patient was hospitalized.

6865401-0 | Bronchial Obstruction, Dizziness, Fatigue, Leukocytosis, Malignant Neoplasm Progression, Off Label Use, Pleural Effusion, Radiation Pneumonitis, Tachycardia
Adverse event was reported on Jul 12, 2010 by a Female patient taking Alimta (View Usage) (Dosage: 825 Mg, Unk) . Location: UNITED STATES , weighting 126.0 lb, After Alimta was administered, patient had the following side effects: bronchial obstruction, dizziness (What is dizziness?), fatigue, leukocytosis, malignant neoplasm progression, off label use, pleural effusion, radiation pneumonitis, tachycardia. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), MORPHINE (View Morphine Review and Morphine Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), XANAX (View Xanax Review and Xanax Label ), ZOFRAN (View Zofran Review and Zofran Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

6861246-6 | Atelectasis, Cardiomegaly, Kidney Fibrosis, Malignant Neoplasm Progression, Pleural Effusion, Pneumonia, Pulmonary Fibrosis, Renal Arteriosclerosis, Renal Failure
on Jul 13, 2010 Male patient from UNITED STATES , weighting 207.0 lb, was diagnosed with lung adenocarcinoma and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: atelectasis, cardiomegaly, kidney fibrosis, malignant neoplasm progression, pleural effusion, pneumonia (What is pneumonia?), pulmonary fibrosis (What is pulmonary fibrosis?), renal arteriosclerosis, renal failure. Alimta dosage: 500 Mg/m2, Every 21 Days. During the same period patient was treated with VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DECADRON (20 Mg, Other) (View Decadron Review and Decadron Label ), VICODIN (View Vicodin Review and Vicodin Label ), PALONOSETRON (0.25 Mg, Unk) (View Palonosetron Review and Palonosetron Label ), FUROSEMIDE (Unk, As Needed) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6857464-3 | Diarrhoea, Disease Progression, Fatigue, Mouth Ulceration, Sepsis
on Jul 08, 2010 Male patient from UNITED KINGDOM , 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta (View Usage). Patient had the following side effects: diarrhoea, disease progression, fatigue, mouth ulceration, sepsis (What is sepsis?). Alimta dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

6851174-4 | Condition Aggravated, Haemoptysis
Patient was taking Alimta (View Usage). After Alimta was administered, patient had the following side effects: condition aggravated, haemoptysis on Jul 14, 2010 from JAPAN Additional patient health information: Male patient , 55 years of age, was diagnosed with non-small cell lung cancer and. Alimta dosage: 500 Mg/m2, Unk. During the same period patient was treated with CISPLATIN (75 Mg/m2, Unk) (View Cisplatin Review and Cisplatin Label ).

6851173-2 | Bronchial Obstruction, Dizziness, Fatigue, Leukocytosis, Malignant Neoplasm Progression, Off Label Use, Pleural Effusion, Radiation Pneumonitis, Tachycardia
Adverse event was reported on Jul 12, 2010 by a Female patient taking Alimta (View Usage) (Dosage: 825 Mg, Unk) . Location: UNITED STATES , weighting 126.0 lb, Patient experienced the following unwanted or unexpected effects: bronchial obstruction, dizziness (What is dizziness?), fatigue, leukocytosis, malignant neoplasm progression, off label use, pleural effusion, radiation pneumonitis, tachycardia. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), MORPHINE (View Morphine Review and Morphine Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), XANAX (View Xanax Review and Xanax Label ), ZOFRAN (View Zofran Review and Zofran Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

6844960-8 | Pericarditis, Platelet Count Decreased
on Jul 05, 2010 Female patient from JAPAN , weighting 101.4 lb, was diagnosed with lung adenocarcinoma stage ii, prophylaxis, pneumonitis and was treated with Alimta (View Usage). Patient had the following side effects: pericarditis, platelet count decreased. Alimta dosage: 692 Mg, Other. During the same period patient was treated with CARBOPLATIN (388 Mg, Other) (View Carboplatin Review and Carboplatin Label ), PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), MUCOSTA (300 Mg, Daily (1/d)) (View Mucosta Review and Mucosta Label ), PREDONINE (2.5 Mg, Daily (1/d)) (View Predonine Review and Predonine Label ), VITAMIN B 12 (Unk, Other) (View Vitamin B-12 Review and Vitamin B-12 Label ). Patient was hospitalized.

6844958-X | Pneumatosis Intestinalis
on Jul 07, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with lung adenocarcinoma stage iv and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: pneumatosis intestinalis. Alimta dosage: .

6843879-6 | Breast Swelling, Localised Oedema, Mass, Mediastinal Mass, Oedema Peripheral, Superior Vena Caval Occlusion, Swelling Face, Tumour Compression
Patient was taking Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: breast swelling, localised oedema, mass, mediastinal mass, oedema peripheral, superior vena caval occlusion, swelling face, tumour compression on Jul 14, 2010 from UNITED STATES Additional patient health information: Female patient , 37 years of age, weighting 169.8 lb, was diagnosed with sarcoma and. Alimta dosage: 885mg Q2 Wks. Iv. During the same period patient was treated with TAXOTERE (88mg Q2 Wks. Iv) (View Taxotere Review and Taxotere Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), KYTRIL (View Kytril Review and Kytril Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6840659-2 | Dyspnoea, Pain
Adverse event was reported on Jul 13, 2010 by a Male patient taking Alimta (View Usage) (Dosage: Alimta Q21 Days Iv) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , 58 years of age, weighting 231.5 lb, Patient had the following side effects: dyspnoea, pain (What is pain?). During the same period patient was treated with CISPLATIN (Cisplatin Q21 Days Iv) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6836727-1 | Anaemia, Epistaxis, Lung Neoplasm Malignant, Neutropenia, Renal Failure, Respiratory Failure, Thrombocytopenia
on Jul 07, 2010 Male patient from BRAZIL , 56 years of age, was diagnosed with adenocarcinoma and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: anaemia, epistaxis, lung neoplasm malignant, neutropenia, renal failure, respiratory failure, thrombocytopenia. Alimta dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ).

6832379-5 | Hyponatraemia, Pyrexia, Tuberculous Pleurisy
on Jul 02, 2010 Male patient from JAPAN , 65 years of age, weighting 123.5 lb, was diagnosed with lung adenocarcinoma recurrent and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia, pyrexia, tuberculous pleurisy. Alimta dosage: Unk, Other. During the same period patient was treated with PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), OMEPRAL (20 Mg, Daily (1/d)) (View Omepral Review and Omepral Label ), MUCOSTA (100 Mg, 3/d) (View Mucosta Review and Mucosta Label ), CALONAL (400 Mg, 4/d) (View Calonal Review and Calonal Label ), MAGMITT (330 Mg, 3/d) (View Magmitt Review and Magmitt Label ), OXYCONTIN (15 Mg, 2/d) (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

6832377-1 | Pleural Effusion
Patient was taking Alimta (View Usage). Patient had the following side effects: pleural effusion on Jul 07, 2010 from UNITED STATES Additional patient health information: Male patient , 38 years of age, . Alimta dosage: .

6832376-X | Chronic Lymphocytic Leukaemia
Adverse event was reported on Jun 30, 2010 by a Male patient taking Alimta (View Usage) (Dosage: 500 Mg/m2, Other (every 3 Weeks)) was diagnosed with lung adenocarcinoma, vitamin supplementation and. Location: FRANCE , 70 years of age, After Alimta was administered, patient had the following side effects: chronic lymphocytic leukaemia. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6832314-X | Dermatitis Bullous, Rash Erythematous
on Jul 02, 2010 Female patient from BELGIUM , weighting 132.3 lb, was diagnosed with lung neoplasm, antiemetic supportive care and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis bullous, rash erythematous. Alimta dosage: 500 Mg/m2, Once. During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), LITICAN (View Litican Review and Litican Label ), ZOFRAN (View Zofran Review and Zofran Label ), MEDROL (View Medrol Review and Medrol Label ).

6828362-6 | Cellulitis, Pancytopenia
on Jul 08, 2010 Female patient from UNITED STATES , 72 years of age, was treated with Alimta (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?), pancytopenia. Alimta dosage: 800 Mg Every 28 Days Iv. During the same period patient was treated with CARBOLPATIN (View Carbolpatin Review and Carbolpatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ). Patient was hospitalized.

6828353-5 | Pancytopenia, Pulmonary Embolism
Patient was taking Alimta (View Usage). After Alimta was administered, patient had the following side effects: pancytopenia, pulmonary embolism (What is pulmonary embolism?) on Jul 08, 2010 from UNITED STATES Additional patient health information: Male patient , 70 years of age, . Alimta dosage: 1100 Mg Iv. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6827192-9 | Fall, Haematocrit Decreased, Hospice Care, Malignant Neoplasm Progression, Neutrophil Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Jul 02, 2010 by a Female patient taking Alimta (View Usage) (Dosage: 900 Mg, Unk) was diagnosed with non-small cell lung cancer stage iv, pain (What is pain?) and. Location: UNITED STATES , weighting 158.6 lb, Patient experienced the following unwanted or unexpected effects: fall (What is fall?), haematocrit decreased, hospice care (What is hospice care?), malignant neoplasm progression, neutrophil count decreased, white blood cell count decreased. During the same period patient was treated with CARBOPLATIN (6 Unk, Unk) (View Carboplatin Review and Carboplatin Label ), AVASTIN (1000 Mg, Unk) (View Avastin Review and Avastin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

6827189-9 | Accidental Overdose, Incorrect Dose Administered
on Jun 28, 2010 Female patient from FRANCE , 85 years of age, was diagnosed with non-small cell lung cancer, vitamin supplementation, prophylaxis and was treated with Alimta (View Usage). Patient had the following side effects: accidental overdose, incorrect dose administered. Alimta dosage: . During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (Unk, Unk) (View Vitamin B-12 Review and Vitamin B-12 Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ).

6827188-7 | Dehydration, Diarrhoea, Malignant Neoplasm Progression, Neutropenia, Performance Status Decreased
on Jun 29, 2010 Male patient from UNITED STATES , 66 years of age, was diagnosed with adenocarcinoma and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: dehydration, diarrhoea, malignant neoplasm progression, neutropenia, performance status decreased. Alimta dosage: 50 Mg/m2, Unk. During the same period patient was treated with CARBOPLATIN (5.5 Unk, Unk) (View Carboplatin Review and Carboplatin Label ), NEULASTA (View Neulasta Review and Neulasta Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

6827187-5 | Dehydration, Diarrhoea, Fatigue, Pancytopenia, Renal Failure
Patient was taking Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, fatigue, pancytopenia, renal failure on Jun 29, 2010 from UNITED STATES Additional patient health information: Male patient , 70 years of age, was diagnosed with lung adenocarcinoma and. Alimta dosage: 50 Mg/m2, Unk. During the same period patient was treated with CARBOPLATIN (5 Unk, Unk) (View Carboplatin Review and Carboplatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

6823182-0 | Hepatic Function Abnormal
Adverse event was reported on Jun 30, 2010 by a Male patient taking Alimta (View Usage) (Dosage: Unk, Other) . Location: JAPAN , 77 years of age, Patient had the following side effects: hepatic function abnormal. Patient was hospitalized.

6823181-9 | Hiccups
on Jun 29, 2010 Male patient from GERMANY , 64 years of age, weighting 156.5 lb, was diagnosed with pleural mesothelioma and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: hiccups. Alimta dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6820014-1 | Interstitial Lung Disease, Malignant Neoplasm Progression, Pulmonary Fibrosis
on Jun 30, 2010 Female patient from FRANCE , 47 years of age, was diagnosed with lung adenocarcinoma, vitamin supplementation, prophylaxis, chest pain (What is chest pain?) and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, malignant neoplasm progression, pulmonary fibrosis (What is pulmonary fibrosis?). Alimta dosage: 500 Mg/m2, 3/w. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), EMEND (View Emend Review and Emend Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), BI PROFENID (View Bi-profenid Review and Bi-profenid Label ). Patient was hospitalized.

6820013-X | Pneumonia, Pyrexia, Systemic Inflammatory Response Syndrome, Urticaria
Patient was taking Alimta (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?), pyrexia, systemic inflammatory response syndrome, urticaria on Jun 24, 2010 from UNITED STATES Additional patient health information: Male patient , 56 years of age, was diagnosed with lung neoplasm malignant and. Alimta dosage: 975 Mg, Unk. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), BENADRYL (View Benadryl Review and Benadryl Label ). Patient was hospitalized.